These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 20944077)
1. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections. Safaeian M; Porras C; Schiffman M; Rodriguez AC; Wacholder S; Gonzalez P; Quint W; van Doorn LJ; Sherman ME; Xhenseval V; Herrero R; Hildesheim A; J Natl Cancer Inst; 2010 Nov; 102(21):1653-62. PubMed ID: 20944077 [TBL] [Abstract][Full Text] [Related]
2. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica. Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M; Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178 [TBL] [Abstract][Full Text] [Related]
3. Empirical sample-specific approaches to define HPV16 and HPV18 seropositivity in unvaccinated, young, sexually active women. Ng K; Morais S; Wissing MD; Burchell AN; Tellier P-P; Coutlée F; Waterboer T; El-Zein M; Franco EL Microbiol Spectr; 2024 Jun; 12(6):e0022924. PubMed ID: 38687066 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure. Coseo SE; Porras C; Dodd LE; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M; Sex Transm Dis; 2011 Oct; 38(10):976-82. PubMed ID: 21934576 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay. Robbins HA; Waterboer T; Porras C; Kemp TJ; Pawlita M; Rodriguez AC; Wacholder S; Gonzalez P; Schiller JT; Lowy DR; Esser M; Matys K; Poncelet S; Herrero R; Hildesheim A; Pinto LA; Safaeian M Hum Vaccin Immunother; 2014; 10(10):2965-74. PubMed ID: 25483632 [TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus. Robbins HA; Li Y; Porras C; Pawlita M; Ghosh A; Rodriguez AC; Schiffman M; Wacholder S; Kemp TJ; Gonzalez P; Schiller J; Lowy D; Esser M; Matys K; Quint W; van Doorn LJ; Herrero R; Pinto LA; Hildesheim A; Waterboer T; Safaeian M BMC Infect Dis; 2014 Mar; 14():120. PubMed ID: 24588945 [TBL] [Abstract][Full Text] [Related]
8. [Distribution of serum antibodies against human papillomavirus 16 and 18 among high-risk women to cervical cancer]. Fei M; Li J; Du J; You J; Zhang S; He W; Kang L; Zhao F; Qiao Y; Si Y; Fan X; Chen W Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May; 35(5):514-8. PubMed ID: 25059358 [TBL] [Abstract][Full Text] [Related]
9. Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial. Safaeian M; Kemp TJ; Pan DY; Porras C; Rodriguez AC; Schiffman M; Cortes B; Katki H; Wacholder S; Schiller JT; Gonzalez P; Penrose K; Lowy DR; Quint W; van Doorn LJ; Herrero R; Hildesheim A; Pinto LA Hum Vaccin Immunother; 2013 Jul; 9(7):1399-406. PubMed ID: 23571174 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial. Kreimer AR; Sampson JN; Porras C; Schiller JT; Kemp T; Herrero R; Wagner S; Boland J; Schussler J; Lowy DR; Chanock S; Roberson D; Sierra MS; Tsang SH; Schiffman M; Rodriguez AC; Cortes B; Gail MH; Hildesheim A; Gonzalez P; Pinto LA; J Natl Cancer Inst; 2020 Oct; 112(10):1038-1046. PubMed ID: 32091594 [TBL] [Abstract][Full Text] [Related]
11. Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial. Safaeian M; Sampson JN; Pan Y; Porras C; Kemp TJ; Herrero R; Quint W; van Doorn LJ; Schussler J; Lowy DR; Schiller J; Schiffman MT; Rodriguez AC; Gail MH; Hildesheim A; Gonzalez P; Pinto LA; Kreimer AR; J Natl Cancer Inst; 2018 Feb; 110(2):205-12. PubMed ID: 28954299 [TBL] [Abstract][Full Text] [Related]
12. Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials. Baisley K; Kemp TJ; Mugo NR; Whitworth H; Onono MA; Njoroge B; Indangasi J; Bukusi EA; Prabhu PR; Mutani P; Galloway DA; Mwanzalime D; Kapiga S; Lacey CJ; Hayes RJ; Changalucha J; Pinto LA; Barnabas RV; Watson-Jones D Lancet Glob Health; 2024 Mar; 12(3):e491-e499. PubMed ID: 38365419 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials. Tota JE; Struyf F; Sampson JN; Gonzalez P; Ryser M; Herrero R; Schussler J; Karkada N; Rodriguez AC; Folschweiller N; Porras C; Schiffman M; Schiller JT; Quint W; Kreimer AR; Wheeler CM; Hildesheim A; J Natl Cancer Inst; 2020 Aug; 112(8):818-828. PubMed ID: 31697384 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. Kreimer AR; González P; Katki HA; Porras C; Schiffman M; Rodriguez AC; Solomon D; Jiménez S; Schiller JT; Lowy DR; van Doorn LJ; Struijk L; Quint W; Chen S; Wacholder S; Hildesheim A; Herrero R; Lancet Oncol; 2011 Sep; 12(9):862-70. PubMed ID: 21865087 [TBL] [Abstract][Full Text] [Related]
15. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species. Gambhira R; Gravitt PE; Bossis I; Stern PL; Viscidi RP; Roden RB Cancer Res; 2006 Dec; 66(23):11120-4. PubMed ID: 17145854 [TBL] [Abstract][Full Text] [Related]
16. Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial. Lang Kuhs KA; Gonzalez P; Rodriguez AC; van Doorn LJ; Schiffman M; Struijk L; Chen S; Quint W; Lowy DR; Porras C; DelVecchio C; Jimenez S; Safaeian M; Schiller JT; Wacholder S; Herrero R; Hildesheim A; Kreimer AR; J Infect Dis; 2014 Dec; 210(12):1890-9. PubMed ID: 24958910 [TBL] [Abstract][Full Text] [Related]
17. Determinants of seropositivity among HPV-16/18 DNA positive young women. Porras C; Bennett C; Safaeian M; Coseo S; Rodríguez AC; González P; Hutchinson M; Jiménez S; Sherman ME; Wacholder S; Solomon D; van Doorn LJ; Bougelet C; Quint W; Schiffman M; Herrero R; Hildesheim A; BMC Infect Dis; 2010 Aug; 10():238. PubMed ID: 20698998 [TBL] [Abstract][Full Text] [Related]
18. An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) Study. Beachler DC; Pinto LA; Kemp TJ; Nyitray AG; Hildesheim A; Viscidi R; Schussler J; Kreimer AR; Giuliano AR Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):496-502. PubMed ID: 29475967 [No Abstract] [Full Text] [Related]
19. Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial. Safaeian M; Porras C; Pan Y; Kreimer A; Schiller JT; Gonzalez P; Lowy DR; Wacholder S; Schiffman M; Rodriguez AC; Herrero R; Kemp T; Shelton G; Quint W; van Doorn LJ; Hildesheim A; Pinto LA; Cancer Prev Res (Phila); 2013 Nov; 6(11):1242-50. PubMed ID: 24189371 [TBL] [Abstract][Full Text] [Related]
20. Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials. Safaeian M; Castellsagué X; Hildesheim A; Wacholder S; Schiffman MH; Bozonnat MC; Baril L; Rosillon D; J Infect Dis; 2018 Jun; 218(1):84-94. PubMed ID: 29718393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]